The Sanofi-DNDI Alliance Receives Global Award

Mar 20, 2014 10:00 AM ET
Campaign: Sanofi Global

March 20, 2014 /3BL Media/ - Sanofi and the Drugs for Neglected Diseases initiative (DNDi), an independent not-for-profit foundation, have received the 2014 Corporate Social Responsibility Alliance Excellence Award, from the Association of Strategic Alliance Professionals (ASAP), in recognition of the “profound, measurable, and positive social impact” that this decade-long public-private partnership has had in the fight against malaria.

This award - Alliance for Corporate Social Responsibility “is the one that always gets me choked up, because the work you do is not just for the sake of revenue, but also for the benefit of your fellow man,” ASAP CEO Michael Leonetti commented.

Malaria is one of the deadliest infectious diseases in the world. According to the World Health Organization (WHO), 207 million cases and 627,000 deaths were reported in 2012, 90% of them in Africa

Developed through this innovative partnership between DNDi and Sanofi, the un-patented ASAQ Winthrop® treatment is now available in most malaria-affected countries in Africa. Since its launch in 2007, over 280 million treatments have been made available to malaria endemic countries in Africa.

“The Sanofi-DNDi alliance is exemplary in that it involved two partners from widely different worlds: Sanofi, a global healthcare leader, and DNDi, an NGO intent on challenging the pharmaceutical industry,” said Dr Robert Sebbag, Vice President, Access to Medicines, Sanofi. “This alliance started in 2004 with very ambitious goals: to develop within the shortest possible timeframe a high-quality, non-patented, affordable and easy to use fixed-dose combination antimalarial drug adapted to the needs of African patients, especially children”

This Alliance has enabled Sanofi to establish other successful partnerships with African National Malaria Control Programs, local experts and NGOs working towards malaria elimination, through a comprehensive approach including education and prevention initiatives.

“This award places Sanofi among alliance leaders, and shows what can be achieved through good alliance management practices,” said Thierry Saugier, Vice President Alliances and Partnerships.

http://www.youtube.com/watch?feature=player_embedded&v=64yeIUS4Ixc

 

References:

1. WHO – World Malaria Report 2013